At a glance
ClinicalIndex Comparison RecordEarly Ph 1Completed· 17 enrolled
Drug / intervention
Magnesium Oxide +2 moredrug
Likely dose
Zofran ODT 4 MG Disintegrating Oral Tabletfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Cohort Study Evaluating the Efficacy of PO Magnesium in the Treatment of Acute Traumatic Brain Injury in Adolescents
In Brief
A Early Phase 1 clinical trial evaluating Magnesium Oxide, Acetaminophen, and 1 other intervention for Concussion Post Syndrome. Completed, enrolled 17 participants across 1 site.
Detailed Summary
The objective of this study is to evaluate the efficacy of magnesium in symptomatic reduction of mild traumatic brain injury in the adolescent population in the acute setting of injury.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsConcussion Post Syndrome
CountriesUnited States
CollaboratorsMichigan State University
Timeline
Early Ph 1CompletedFinished
201820192020202120222023202420252026
Enrollment StartSep 2017
First PostedMar 2018
Primary CompletionNov 2019
Study CompletionDec 2019
TodayJul 2026
First PostedMar 23, 2018
Enrollment StartSep 1, 2017
Primary CompletionNov 30, 2019
Study CompletionDec 30, 2019
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 8.3 years ago
Interventions
Magnesium Oxidedrug
400 mg Magnesium oxide tablet given once in the ED, and prescribed to take BID for 5 days total after discharge
Acetaminophendrug
500 mg tablets given once in the ED, and prescribed to take BID for 5 days total after discharge.
Zofran ODT 4 MG Disintegrating Oral Tabletdrug
Given once in the Emergency department